التهاب الرحم مصنع, شراء نوعية جيدة التهاب الرحم المنتجات من الصين

1-[2-فلورو-6- ((تريفلوروميثيل) البنزيل]-5-يود-6-ميثيلبيريميدين-2,4 ((1H,3H) -ديون (1150560-54-5)

1-[2-fluoro-6-(trifluoromethyl)benzyl]-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione is an intermediate of Elagolix Sodium. Product Name: 1-[2-fluoro-6-(trifluoromethyl)benzyl]-5-iodo-6-methylpyrimidine-2,4(1H,3H)-dione CAS No.: 1150560-54-5 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C13H9F4IN2O2 Molecular Weight: 428.12 Shelf Life: 2 Years Package: 25kg/drum

5-برومو-1-(2-فلورو-6-تريفلوروميثيل-بنزيل)-6-ميثيل-1H-بيريميدين-2,4-ديون (830346-48-0)

5-Bromo-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione is an intermediate of Elagolix Sodium. Product Name: 5-Bromo-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione CAS No.: 830346-48-0 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C13H9F4BrN2O2 Molecular Weight: 381.12 Shelf Life: 2 Years Package: 25kg/drum

5- ((2-فلورو-3-ميتوكسيفينيل)-1-[[2-فلورو-6-(تريفلوروميثيل) فينيل]ميثيل]-6-ميثيل-2,4(1H,3H) - بيريميدين (1150560-59-0)

5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione is an intermediate of Elagolix Sodium. Product Name: 5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidin CAS No.: 1150560-59-0 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C20H15F5N2O3 Molecular Weight: 426.34 Shelf Life: 2 Years Package: 25kg/drum

حمض البنزين الخلوي، 4-فلورو-ألفا- ((1-ميثيل إيثيل) ، (.ألفا.S) - (830346-47-9)

Benzeneacetic acid, 4-fluoro-.alpha.-(1-methylethyl)-, (.alpha.S)- is a key intermediate of Elagolix Sodium. Product Name: Benzeneacetic acid, 4-fluoro-.alpha.-(1-methylethyl)-, (.alpha.S)- CAS No.: 830346-47-9 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C13H10F4N2O2 Molecular Weight: 302.22 Shelf Life: 2 Years Package: 25kg/drum

إيلاجوليكس الصوديوم (832720-36-2)

Elagolix sodium (ABT-620) is a small molecule, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist. It has the ability to suppress estradiol (E2) concentrations in a dose-dependent manner. Elagolix is the first orally available GnRH antagonist, and as such may provide patients with relief from the painful symptoms of endometriosis while offering advantages over currently available injectable peptide-based treatments. The estimated patient population is

حمض 2-فلورو-3-ميتوكسيفينيل بورونيك (352303-67-4)

2-fluoro-3-methoxyphenylboronic acid is an intermediate of Elagolix Sodium. Product Name: 2-fluoro-3-methoxyphenylboronic acid CAS No.: 352303-67-4 Assay: 98% End Use: Elagolix Sodium Molecular Formula: C7H8BFO3 Molecular Weight: 169.95 Shelf Life: 2 Years Package: 25kg/drum